This is a condition that can happen in people with advanced liver disease. It affects the blood vessels in the lungs, making it hard for oxygen to get into the blood. It's often linked to cirrhosis.
Every report comes from a Lived member, sent anonymously.
Have you had Liver Transplant for Hepatopulmonary Syndrome?
Hepatopulmonary syndrome (HPS) is a lung complication of liver disease. Tiny blood vessels in the lungs become abnormally widened, so blood rushes through them too quickly to pick up enough oxygen. The result is a low oxygen level in the blood, even though the lungs themselves are otherwise healthy. The main symptom is shortness of breath, which tends to build gradually and can limit everyday activity. A distinctive feature is breathlessness that gets worse when sitting or standing up and eases when lying down, because gravity sends more blood through the widened vessels at the bottom of the lungs. Some people also have marked tiredness, a bluish tinge to the lips or fingers, or rounded, enlarged fingertips (clubbing). Others have no breathing symptoms at all, and the condition is found during testing for a liver transplant.
HPS develops in people with chronic liver disease, most often cirrhosis (scarring of the liver), and in people with portal hypertension, which is raised blood pressure in the vein that carries blood from the gut to the liver. It is fairly common in this group: studies find it in up to about 3 in 10 people with advanced cirrhosis and portal hypertension, depending on how carefully it is looked for. Researchers believe the damaged liver fails to clear, or overproduces, substances that relax blood vessels, including nitric oxide, and that inflammation and bacterial products from the gut also play a part. These signals cause the lung vessels to widen and new abnormal vessels to form. HPS does not simply track the severity of the liver disease, so it can appear in people whose liver is otherwise holding up reasonably well. A related but different condition, portopulmonary hypertension, also arises from portal hypertension. In that case the lung arteries narrow and lung pressures rise, which needs a different treatment approach.
HPS is often missed, because breathlessness in liver disease is easily put down to fluid, muscle loss or tiredness. Diagnosis requires three things together: liver disease or portal hypertension, a problem getting oxygen into the blood, and evidence of widened blood vessels in the lungs. Other heart and lung conditions that could explain low oxygen also need to be considered. Oxygen is measured with an arterial blood gas, a blood sample usually taken from an artery at the wrist while breathing room air. It shows the pressure of oxygen in the blood and how large the gap is between the oxygen in the lungs and the oxygen that reaches the blood. A widened gap points to a gas exchange problem. The oxygen pressure also sets the severity: about 80 mmHg or above is mild, 60 to 79 is moderate, 50 to 59 is severe and below 50 is very severe. A fingertip pulse oximeter reading is useful for tracking, but a normal reading does not rule HPS out. The widened vessels are found with a contrast echocardiogram, sometimes called a bubble study. Harmless tiny bubbles in saltwater are injected into a vein while an ultrasound watches the heart. Normally the lungs filter the bubbles out; if they appear on the left side of the heart a few heartbeats later, they have slipped through widened lung vessels. Timing helps separate this from a hole in the heart. A lung scan using a small amount of radioactive tracer can sometimes measure how much blood bypasses the lungs, and lung function tests or a chest scan help exclude other causes.
Liver transplantation is the only treatment that reverses HPS. Because the syndrome raises the risk of death for people with liver disease, having HPS is a reason to be evaluated for a transplant even when the liver disease would not otherwise call for one. In the United States, people with HPS and significantly low oxygen can be given extra priority on the transplant waiting list. Transplant teams generally aim to operate before oxygen levels fall very low, because the operation and recovery are riskier when HPS is very severe. Supplemental oxygen is the main way to manage symptoms while waiting or when transplant is not an option. It raises blood oxygen and can make breathing and activity easier, but it does not change the underlying disease. Oxygen works best when the problem is many small widened vessels, which is the usual pattern. A less common form involves larger direct connections between arteries and veins in the lungs, which respond poorly to oxygen and can sometimes be closed off with a catheter procedure. Several medicines have been tried, including pentoxifylline, methylene blue and the antibiotic norfloxacin, but none has been shown to reliably reverse HPS, and a placebo-controlled trial of pentoxifylline found no benefit. A shunt placed inside the liver to lower portal pressure (TIPS, a transjugular intrahepatic portosystemic shunt) has helped some people and worsened oxygen levels in others, so it is not a standard treatment for HPS itself.
Without a transplant, HPS usually worsens over time, although the pace varies. Breathlessness and fatigue can increasingly limit walking, stairs and other daily activities, and some people come to need oxygen for exertion, sleep or all day. In some people oxygen falls quickly over months, which is a sign the disease is progressing faster and the transplant plan may need to move sooner. Regular oxygen checks with blood gases are part of follow-up for this reason. After a successful transplant the outlook is generally good. Survival after transplant is similar to that of people transplanted for other reasons, though people with very severe HPS beforehand need closer monitoring and recover more slowly. Oxygen levels usually begin to improve within weeks to months, and in most people the syndrome resolves completely within about a year as the lung vessels return to normal.
If you have liver disease or portal hypertension and notice new or gradually worsening shortness of breath, especially breathlessness that is worse when you sit or stand up, ask your liver team about testing for HPS. Bring it up even if your liver disease has been stable, since HPS can develop independently of liver function. If you already have HPS, contact your care team promptly if your breathing gets worse quickly, you need more oxygen than usual to reach your target reading, or your lips or fingers look more blue than before. A rapid decline can change the timing of transplant.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Hepatopulmonary Syndrome is like, what's helped you, or ask the community a question.